CTNNB1 and Ehlers-Danlos syndrome, musculocontractural type: In ATCs and PDTCs, CTNNB1 (0-25% in PDTCs, 66% in ATCs) and TP53 mutations (20-38% in PDTCs; 67-88% in ATCs) were observed [2,11,12,15,16].